The impact of adjuvant antihormonal therapy versus observation on recurrence of borderline ovarian tumors: A retrospective cohort study
Objectives: Adjuvant management of borderline ovarian tumors (BOT) after surgical diagnosis and staging is not standardized. While many patients undergo observation alone, some providers have introduced the use of adjuvant antihormonal therapy for BOT, extrapolating from studies suggesting improveme...
Saved in:
Main Authors: | Kelsey C. Goon (Author), Jeanelle Sheeder (Author), Miriam D. Post (Author), Jill Alldredge (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can we safely forgo hysterectomy in non-fertility-sparing surgery for borderline ovarian tumors?
by: Breana L. Hill, et al.
Published: (2021) -
Recurrence characteristics and clinicopathological results of borderline ovarian tumors
by: Lina Niu, et al.
Published: (2021) -
Identification of factors that impact recurrence in patients with borderline ovarian tumors
by: Xi Chen, et al.
Published: (2017) -
Management of Borderline Ovarian Tumors
by: Chuenkamon Charakorn
Published: (2018) -
To the issue of borderline ovarian tumors
by: A. G. Solopova, et al.
Published: (2018)